NCT04662177View on ClinicalTrials.gov

Co-administration of Dexmedetomidine in Carotid Endarterectomy (CEA)

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

October 16, 2020

Study Completion Date

December 4, 2020

Conditions
Carotid Stenosis
Interventions
DRUG

Dexmedetomidine

The study participants are divided into two groups: Group 1 starts with a bolus of dexmedetomidine 0.4 µg/kg over 10 minutes, followed by con-tinuous infusion of dexmedetomidine 0.4 µg/kg/h until the end of burst suppression. Group 2 receives the standard anaesthesia management.

Trial Locations (1)

3010

Inselspital Bern, Bern

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT04662177 - Co-administration of Dexmedetomidine in Carotid Endarterectomy (CEA) | Biotech Hunter | Biotech Hunter